ReviewMolecular neurobiology2026
Targeting Autophagy, Ferroptosis, and Neuroinflammation: Polyphenol-Mediated Modulation of Emerging Signaling Pathways in Neurodegeneration.
Review in Molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- ZBP1-mediated Treg cell dysfunction exacerbates neuroimmune dysregulation in Alzheimer's disease under metabolic stress.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Complex, intertwined processes, including impaired autophagy, ferroptosis, and chronic neuroinflammation, drive neurodegenerative disorders (NDD). Polyphenols, a class of plant-derived natural compounds, are emerging as promising modulators of these pathogenic mechanisms, acting via diverse signaling pathways. This review summarized the molecular underpinnings of autophagy dysfunction, ferroptotic cell death, and inflammatory signaling in the central nervous system (CNS). Focusing mainly on key regulators such as AMPK, mTOR, Beclin-1, GPX4, NRF2, p62/Keap1, and system Xc⁻. Additionally, the evidence for polyphenol-mediated modulation of these pathways was also examined and covered in this study, along with highlighting compounds such as kaempferol, curcumin, resveratrol, epigallocatechin-3-gallate (EGCG), and many more. Polyphenols restore autophagic flux, suppress lipid peroxidation, restore redox balance, stabilizes mitochondrial function, and downregulate pro-inflammatory transcription factors (e.g., NF-κB, MAPKs). Furthermore, the interlink between autophagy and ferroptosis, such as ferritinophagy and lipophagy, as well as the dual roles of autophagy in either promoting or preventing ferroptosis depending on the cellular context, were also covered. The role of polyphenols in modulating these intersections to mitigate neuronal damage. Last, this review discussed the translational implications, including challenges in bioavailability, blood-brain barrier (BBB) penetration, and metabolic stability of polyphenols. Also, major potential therapeutic strategies include nanoformulations, targeted delivery, combinatorial therapies, and gaps such as timing, dosing, selectivity, and in vivo evidence in human disease. This review elucidates how polyphenols can harness emerging signaling nodes to yield novel therapeutic strategies for NDD by integrating insights across autophagy, ferroptosis, and neuroinflammation.
Indexed as
Identifiers
41746549What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.